Torsemide and Venous occlusion - a phase IV clinical study of FDA data

Summary:

Venous occlusion is reported as a side effect among people who take Torsemide (torsemide), especially for people who are male, 60+ old, also take Demadex, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Venous occlusion when taking Torsemide. It is created by eHealthMe based on reports of 32,825 people who have side effects when taking Torsemide from the FDA, and is updated regularly.

What is Torsemide?

Torsemide has active ingredients of torsemide. It is often used in high blood pressure. eHealthMe is studying from 33,072 Torsemide users. Check the latest studies of Torsemide.

What is Venous occlusion?

Venous occlusion (the blocking of venous return) is found to be associated with 339 drugs and 433 conditions by eHealthMe. Check the latest studies of Venous occlusion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

32,825 people reported to have side effects when taking Torsemide.
Among them, 13 people (0.04%) have Venous occlusion.

Among these 13 people:

What is the gender of people who have Venous occlusion when taking Torsemide? *

female: 7.69 %
male: 92.31 %

What is the age of people who have Venous occlusion when taking Torsemide? *

What are other drugs people take besides Torsemide? *

What are other side effects people have besides Venous occlusion? *

Hyperlipidaemia (presence of excess lipids in the blood): 12 people, 92.31%
Weight Decreased: 12 people, 92.31%
Bicytopenia (two parameters from the full blood count are low, the term bicytopenia can be used): 12 people, 92.31%
Gout (uric acid crystals building up in the body): 12 people, 92.31%
Heart Attack: 12 people, 92.31%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 12 people, 92.31%
Herpes Zoster: 12 people, 92.31%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 12 people, 92.31%
High Blood Cholesterol: 12 people, 92.31%
Hypertensive Heart Disease: 12 people, 92.31%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 8 people, 61.54%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 7.69%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 7.69%
Depression: 1 person, 7.69%
Bipolar Disorder (mood disorder): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Torsemide and have Venous occlusion?

- Check whether Venous occlusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Torsemide:

Torsemide (33,072 reports)

Browse all side effects of Torsemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Venous occlusion:

Venous occlusion (339 drugs)

Browse all the conditions that are associated with Venous occlusion:

Venous occlusion (433 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on torsemide (the active ingredients of Torsemide) and Torsemide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.